Continue your liver education from the annual AASLD Liver Meeting® at DDW 2023.
Pandemic-related increases in alcohol use and AUDs warrant increased vigilance from hepatologists.
Hepatologists should take the reins and address palliative care in their end-stage liver disease patients.
Updated AASLD guidance puts an emphasis on high-quality MRI as the seminal diagnostic tool and provides much-needed direction for diagnosing cholangiocarcinoma.
New data suggest that some patients with previously untransplantable cancers can be successfully transplanted.
Everyone between the ages of 18 and 79 should get a one-time screening test for HCV.
Lean patients with NAFLD are more likely to have cardiovascular disease than those with NAFLD who are overweight or living with obesity.
Continue learning about the liver during 2022 at DDW.
With the increased availability of safe and effective treatments for patients with hepatitis C (HCV), Brian L. Pearlman, MD, FACP, FAASLD, AAHIVS, identified five HCV patient populations clinicians should understand how to treat.
Nancy Reau, MD, explored COVID-19-related liver disease in severe and long-term COVID-19 infections.
